Lintuzumab
Jump to navigation
Jump to search
Lintuzumab | |
---|---|
Term | Lintuzumab |
Short definition | Lintuzumab (lin-TOO-zoo-mab) A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Lintuzumab - (pronounced) (lin-TOO-zoo-mab) A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Lintuzumab is a type of monoclonal antibody. Also called MoAb HuM195 and monoclonal antibody HuM195
External links
- Medical encyclopedia article on Lintuzumab
- Wikipedia's article - Lintuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski